A detailed history of Oracle Alpha Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Oracle Alpha Inc. holds 1,071 shares of LLY stock, worth $808,605. This represents 1.49% of its overall portfolio holdings.

Number of Shares
1,071
Previous 1,560 31.35%
Holding current value
$808,605
Previous $909 Million 8.38%
% of portfolio
1.49%
Previous 1.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $289,585 - $387,424
-489 Reduced 31.35%
1,071 $833 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $819,296 - $965,842
1,560 New
1,560 $909 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.